HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

R Herranz Selected Research

IQM-97,423

10/2004Pharmacological study of IQM-97,423, a potent and selective CCK1 receptor antagonist with protective effect in experimental acute pancreatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:
Type Validation Code Shown:


R Herranz Research Topics

Disease

2Rectal Neoplasms (Rectal Cancer)
06/2014 - 12/2001
1Pancreatitis
10/2004
1Neoplasms (Cancer)
12/2001
1Melanoma (Melanoma, Malignant)
08/2001
1Breast Neoplasms (Breast Cancer)
04/2001
1Pain (Aches)
08/2000
1Fever (Fevers)
03/2000
1Paraganglioma (Paragangliomas)
02/2000

Drug/Important Bio-Agent (IBA)

1IQM-97,423IBA
10/2004
1DevazepideIBA
10/2004
1Caerulein (Ceruletide)IBA
10/2004
1Fluorouracil (Carac)FDA LinkGeneric
12/2001
1Radiation-Sensitizing AgentsIBA
12/2001
1TegafurIBA
12/2001
1Complement System Proteins (Complement)IBA
04/2001
1Technetium Tc 99m MedronateIBA
02/2000
13-Iodobenzylguanidine (Iobenguane)IBA
02/2000

Therapy/Procedure

1Neoadjuvant Therapy
06/2014
1Ligation
10/2004
1Radiotherapy
12/2001
1Lymph Node Excision (Lymph Node Dissection)
08/2001
1Analgesia
08/2000
1Homologous Transplantation (Allograft)
03/2000
1Transplants (Transplant)
03/2000